Can age at first pregnancy increase your risk of developing diabetes?…
Read More »The Expansion of the SGLT-2 Inhibitor Market
What’s New on the Horizon? Heather Good, Doctor of Pharmacy, Candidate University of Florida Sodium-glucose co-transporter 2 (SGLT2) inhibitors, the first drugs to actually eliminate glucose from the body, are paving the way for a new wave of diabetes treatment options. Canagliflozin (Invokana®) took the U.S. market by storm when …
Read More »Therapy of Type 2 Diabetes Mellitus, Update, Part 2
In this week’s set of Homerun Slides from Dr. Stanley Schwartz, we delve into the current state of type 2 diabetes treatment further with a closer examination of clinical trial results including the ACCORD trial. With the recent re-approval of Avandia by the FDA, these results are worth taking …
Read More »ADA/JDRF Type 1 Diabetes Sourcebook, Excerpt #17: Insulin, Part 2 of 3
Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor PEDIATRICS – Jane Lee Chiang, MD, and Georgeanna J. Klingensmith, MD ADULTS – Irl B. Hirsch, MD 1. Basal insulin accounts for ~50% of total daily dose: i. LAA (insulin glargine, detemir, degludec) or NPH if LAA …
Read More »Medic Shoes
Medic Shoes Medic Shoes™ are for people who suffer from diabetes-induced leg pain and circulatory problems. These comfortable shoes enhance peripheral circulation and increase blood flow, alleviating symptoms of poor peripheral circulation and neuropathy, including foot pain, burning, cramping, and tingling. The shoes can provide instant relief to these side effects, leading …
Read More »What Do We Know about the Dawn Phenomenon?
Can basal insulin can make a difference?…
Read More »Achieving CV Goals with Weekly Exenatide vs. Sitagliptin or Glargine
Once-weekly exenatide shows benefit in type 2 diabetes patients….
Read More »Risk Factors for Hypoglycemia and Strategies for Avoidance
Minimizing hypoglycemia in type 2 diabetes patients…. Hypoglycemia is a common problem among patients taking combinations of insulin and sulfonylureas and may be a limiting factor in diabetes therapy management. Hypoglycemia is defined by the American Diabetes Association (ADA) as a plasma glucose of 79mg/dL. (3.9mmol/L) or less; however most people …
Read More »Three Diets and Their Effects on Postprandial Glucose Levels
Which of these three popular diets may be more beneficial for patients with type 2 diabetes?…
Read More »Can Being an Athlete in Youth Protect against Type 2 Later in Life?
Former elite athletes, now in their 60s-80s, compared to their current non-athlete peers….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.